| Symbol |
Name |
|
A1CF
|
APOBEC1 complementation factor
|
|
A2M
|
alpha-2-macroglobulin
|
|
AAAS
|
achalasia, adrenocortical insufficiency, alacrimia
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABHD5
|
abhydrolase domain containing 5
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACPP
|
acid phosphatase, prostate
|
|
ACTB
|
actin, beta
|
|
ACVR1
|
activin A receptor, type I
|
|
ACYP1
|
acylphosphatase 1, erythrocyte (common) type
|
|
ADA
|
adenosine deaminase
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADARB1
|
adenosine deaminase, RNA-specific, B1
|
|
ADCY1
|
adenylate cyclase 1 (brain)
|
|
ADCY3
|
adenylate cyclase 3
|
|
ADCY6
|
adenylate cyclase 6
|
|
ADCY7
|
adenylate cyclase 7
|
|
ADCY8
|
adenylate cyclase 8 (brain)
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
|
ADGRG6
|
adhesion G protein-coupled receptor G6
|
|
ADGRV1
|
adhesion G protein-coupled receptor V1
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADPRHL2
|
ADP-ribosylhydrolase like 2
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AFP
|
alpha-fetoprotein
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGRP
|
agouti related neuropeptide
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHI1
|
Abelson helper integration site 1
|
|
AHNAK
|
AHNAK nucleoprotein
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AHSP
|
alpha hemoglobin stabilizing protein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIFM3
|
apoptosis-inducing factor, mitochondrion-associated, 3
|
|
AIM2
|
absent in melanoma 2
|
|
AIRE
|
autoimmune regulator
|
|
AJAP1
|
adherens junctions associated protein 1
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALAS1
|
5'-aminolevulinate synthase 1
|
|
ALB
|
albumin
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1L1
|
aldehyde dehydrogenase 1 family, member L1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDH3A2
|
aldehyde dehydrogenase 3 family, member A2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALKBH1
|
alkB, alkylation repair homolog 1 (E. coli)
|
|
ALKBH5
|
AlkB family member 5, RNA demethylase
|
|
ALMS1
|
Alstrom syndrome protein 1
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
AMH
|
anti-Mullerian hormone
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
|
AMY2A
|
amylase, alpha 2A (pancreatic)
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPTL3
|
angiopoietin-like 3
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANKFY1
|
ankyrin repeat and FYVE domain containing 1
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
ANXA2R
|
annexin A2 receptor
|
|
ANXA5
|
annexin A5
|
|
ANXA7
|
annexin A7
|
|
APC
|
adenomatous polyposis coli
|
|
APLN
|
apelin
|
|
APLNR
|
apelin receptor
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA2
|
apolipoprotein A-II
|
|
APOB
|
apolipoprotein B
|
|
APOBEC1
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOBEC3H
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
|
|
APOC3
|
apolipoprotein C-III
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARFGEF2
|
ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited)
|
|
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARL13B
|
ADP-ribosylation factor-like 13B
|
|
ARL6IP5
|
ADP-ribosylation factor-like 6 interacting protein 5
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ASH1L
|
ash1 (absent, small, or homeotic)-like (Drosophila)
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
|
ASIC3
|
acid sensing (proton gated) ion channel 3
|
|
ASPH
|
aspartate beta-hydroxylase
|
|
ASPN
|
asporin
|
|
ATF2
|
activating transcription factor 2
|
|
ATF4
|
activating transcription factor 4
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATN1
|
atrophin 1
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP6V1H
|
ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATPIF1
|
ATPase inhibitory factor 1
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
ATXN1
|
ataxin 1
|
|
ATXN3
|
ataxin 3
|
|
ATXN7
|
ataxin 7
|
|
ATXN8
|
ataxin 8
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AXIN1
|
axin 1
|
|
B2M
|
beta-2-microglobulin
|
|
B3GNT1
|
|
|
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BAX
|
BCL2-associated X protein
|
|
BAZ1B
|
bromodomain adjacent to zinc finger domain, 1B
|
|
BBC3
|
BCL2 binding component 3
|
|
BCAM
|
basal cell adhesion molecule (Lutheran blood group)
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCL2L14
|
BCL2-like 14 (apoptosis facilitator)
|
|
BCL2L2
|
BCL2-like 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDKRB1
|
bradykinin receptor B1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BEST1
|
bestrophin 1
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMF
|
Bcl2 modifying factor
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
C19ORF80
|
chromosome 19 open reading frame 80
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QB
|
complement component 1, q subcomponent, B chain
|
|
C1QC
|
complement component 1, q subcomponent, C chain
|
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1
|
|
C1QTNF5
|
C1q and tumor necrosis factor related protein 5
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
C5AR2
|
complement component 5a receptor 2
|
|
C6ORF25
|
chromosome 6 open reading frame 25
|
|
C9
|
complement component 9
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CA2
|
carbonic anhydrase II
|
|
CABLES1
|
Cdk5 and Abl enzyme substrate 1
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALB2
|
calbindin 2
|
|
CALCRL
|
calcitonin receptor-like
|
|
CALD1
|
caldesmon 1
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALR
|
calreticulin
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAND1
|
cullin-associated and neddylation-dissociated 1
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAPN3
|
calpain 3, (p94)
|
|
CARD10
|
caspase recruitment domain family, member 10
|
|
CASC5
|
cancer susceptibility candidate 5
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP12
|
caspase 12 (gene/pseudogene)
|
|
CASP14
|
caspase 14, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASQ2
|
calsequestrin 2 (cardiac muscle)
|
|
CASR
|
calcium-sensing receptor
|
|
CASZ1
|
castor zinc finger 1
|
|
CATSPER1
|
cation channel, sperm associated 1
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CBX1
|
chromobox homolog 1
|
|
CBX2
|
chromobox homolog 2
|
|
CBX5
|
chromobox homolog 5
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL14
|
chemokine (C-C motif) ligand 14
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA1
|
cyclin A1
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNF
|
cyclin F
|
|
CCNT1
|
cyclin T1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCS
|
copper chaperone for superoxide dismutase
|
|
CD14
|
CD14 molecule
|
|
CD177
|
CD177 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD1B
|
CD1b molecule
|
|
CD1C
|
CD1c molecule
|
|
CD1D
|
CD1d molecule
|
|
CD2
|
CD2 molecule
|
|
CD200
|
CD200 molecule
|
|
CD209
|
CD209 molecule
|
|
CD22
|
CD22 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD47
|
CD47 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD58
|
CD58 molecule
|
|
CD63
|
CD63 molecule
|
|
CD9
|
CD9 molecule
|
|
CDC14B
|
cell division cycle 14B
|
|
CDC20
|
cell division cycle 20
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC37
|
cell division cycle 37
|
|
CDC42
|
cell division cycle 42
|
|
CDC6
|
cell division cycle 6
|
|
CDC73
|
cell division cycle 73
|
|
CDCA2
|
cell division cycle associated 2
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK11B
|
cyclin-dependent kinase 11B
|
|
CDK19
|
cyclin-dependent kinase 19
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK8
|
cyclin-dependent kinase 8
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2AIP
|
CDKN2A interacting protein
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2B-AS1
|
CDKN2B antisense RNA 1
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CDX1
|
caudal type homeobox 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CDX4
|
caudal type homeobox 4
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEND1
|
cell cycle exit and neuronal differentiation 1
|
|
CENPA
|
centromere protein A
|
|
CEP290
|
centrosomal protein 290kDa
|
|
CFH
|
complement factor H
|
|
CFHR1
|
complement factor H-related 1
|
|
CFI
|
complement factor I
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHMP2B
|
charged multivesicular body protein 2B
|
|
CHP1
|
calcineurin-like EF-hand protein 1
|
|
CHP2
|
calcineurin-like EF-hand protein 2
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CKM
|
creatine kinase, muscle
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLDN1
|
claudin 1
|
|
CLDN5
|
claudin 5
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CLOCK
|
clock circadian regulator
|
|
CLU
|
clusterin
|
|
CNDP2
|
CNDP dipeptidase 2 (metallopeptidase M20 family)
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTN1
|
contactin 1
|
|
COL10A1
|
collagen, type X, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COMMD5
|
COMM domain containing 5
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPT2
|
carnitine palmitoyltransferase 2
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRADD
|
CASP2 and RIPK1 domain containing adaptor with death domain
|
|
CRBN
|
cereblon
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREBZF
|
CREB/ATF bZIP transcription factor
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRIM1
|
cysteine rich transmembrane BMP regulator 1 (chordin-like)
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYBA2
|
crystallin, beta A2
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSTA
|
cystatin A (stefin A)
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTRC
|
chymotrypsin C (caldecrin)
|
|
CTTN
|
cortactin
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL3
|
chemokine (C-X-C motif) ligand 3
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP2A13
|
cytochrome P450, family 2, subfamily A, polypeptide 13
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAO
|
D-amino-acid oxidase
|
|
DAP3
|
death associated protein 3
|
|
DAXX
|
death-domain associated protein
|
|
DCK
|
deoxycytidine kinase
|
|
DCLK1
|
doublecortin-like kinase 1
|
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB104A
|
defensin, beta 104A
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEFT1P
|
defensin, theta 1 pseudogene
|
|
DEL22Q11.2
|
Chromosome 22q11.2 deletion syndrome, distal
|
|
DES
|
desmin
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DHFR
|
dihydrofolate reductase
|
|
DHX9
|
DEAH (Asp-Glu-Ala-His) box helicase 9
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DIXDC1
|
DIX domain containing 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK2
|
dickkopf WNT signaling pathway inhibitor 2
|
|
DLAT
|
dihydrolipoamide S-acetyltransferase
|
|
DLX4
|
distal-less homeobox 4
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMD
|
dystrophin
|
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNM1
|
dynamin 1
|
|
DNM2
|
dynamin 2
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPAGT1
|
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase)
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPT
|
dermatopontin
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DSP
|
desmoplakin
|
|
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila)
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DTX4
|
deltex 4, E3 ubiquitin ligase
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
DVL2
|
dishevelled segment polarity protein 2
|
|
DYNLT1
|
dynein, light chain, Tctex-type 1
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
E2F7
|
E2F transcription factor 7
|
|
E2F8
|
E2F transcription factor 8
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EFNA2
|
ephrin-A2
|
|
EFNB1
|
ephrin-B1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EGR1
|
early growth response 1
|
|
EGR3
|
early growth response 3
|
|
EHF
|
ets homologous factor
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EI24
|
etoposide induced 2.4
|
|
EIF2AK1
|
eukaryotic translation initiation factor 2-alpha kinase 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EIF5A2
|
eukaryotic translation initiation factor 5A2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4
|
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
|
|
ELF4
|
E74-like factor 4 (ets domain transcription factor)
|
|
ELN
|
elastin
|
|
ENG
|
endoglin
|
|
ENGASE
|
endo-beta-N-acetylglucosaminidase
|
|
ENHO
|
energy homeostasis associated
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
ENTPD4
|
ectonucleoside triphosphate diphosphohydrolase 4
|
|
EOMES
|
eomesodermin
|
|
EP300
|
E1A binding protein p300
|
|
EP400
|
E1A binding protein p400
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
EPX
|
eosinophil peroxidase
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERAS
|
ES cell expressed Ras
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERGIC2
|
ERGIC and golgi 2
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ESCO2
|
establishment of sister chromatid cohesion N-acetyltransferase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRP1
|
epithelial splicing regulatory protein 1
|
|
ESRP2
|
epithelial splicing regulatory protein 2
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV5
|
ets variant 5
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXO1
|
exonuclease 1
|
|
EYA3
|
EYA transcriptional coactivator and phosphatase 3
|
|
EZH1
|
enhancer of zeste 1 polycomb repressive complex 2 subunit
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCE
|
Fanconi anemia, complementation group E
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FAT1
|
FAT atypical cadherin 1
|
|
FBXL5
|
F-box and leucine-rich repeat protein 5
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FCMR
|
Fc fragment of IgM receptor
|
|
FCRL3
|
Fc receptor-like 3
|
|
FGA
|
fibrinogen alpha chain
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGF9
|
fibroblast growth factor 9
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FGG
|
fibrinogen gamma chain
|
|
FGL2
|
fibrinogen-like 2
|
|
FHIT
|
fragile histidine triad
|
|
FHL1
|
four and a half LIM domains 1
|
|
FHL3
|
four and a half LIM domains 3
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FIS1
|
fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLG
|
filaggrin
|
|
FLII
|
flightless I homolog (Drosophila)
|
|
FLNA
|
filamin A, alpha
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXA1
|
forkhead box A1
|
|
FOXM1
|
forkhead box M1
|
|
FOXN1
|
forkhead box N1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
FPGS
|
folylpolyglutamate synthase
|
|
FRS3
|
fibroblast growth factor receptor substrate 3
|
|
FRZB
|
frizzled-related protein
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FSTL1
|
follistatin-like 1
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
FUT1
|
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)
|
|
FUT7
|
fucosyltransferase 7 (alpha (1,3) fucosyltransferase)
|
|
FXR1
|
fragile X mental retardation, autosomal homolog 1
|
|
FXR2
|
fragile X mental retardation, autosomal homolog 2
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
FZD8
|
frizzled class receptor 8
|
|
G0S2
|
G0/G1 switch 2
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GABRE
|
gamma-aminobutyric acid (GABA) A receptor, epsilon
|
|
GABRG1
|
gamma-aminobutyric acid (GABA) A receptor, gamma 1
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GABRR1
|
gamma-aminobutyric acid (GABA) A receptor, rho 1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALNT6
|
polypeptide N-acetylgalactosaminyltransferase 6
|
|
GAST
|
gastrin
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GATA6
|
GATA binding protein 6
|
|
GBA
|
glucosidase, beta, acid
|
|
GCDH
|
glutaryl-CoA dehydrogenase
|
|
GCG
|
glucagon
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GCM2
|
glial cells missing homolog 2 (Drosophila)
|
|
GCNT2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)
|
|
GDAP1
|
ganglioside induced differentiation associated protein 1
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF5
|
growth differentiation factor 5
|
|
GH1
|
growth hormone 1
|
|
GH2
|
growth hormone 2
|
|
GHR
|
growth hormone receptor
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLG1
|
golgi glycoprotein 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLIS1
|
GLIS family zinc finger 1
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GLUD2
|
glutamate dehydrogenase 2
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNAI3
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAT2
|
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GNL1
|
guanine nucleotide binding protein-like 1
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GOLM1
|
golgi membrane protein 1
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
|
GP9
|
glycoprotein IX (platelet)
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPR1-AS
|
GPR1 antisense RNA
|
|
GPR182
|
G protein-coupled receptor 182
|
|
GPR183
|
G protein-coupled receptor 183
|
|
GPR4
|
G protein-coupled receptor 4
|
|
GPRC5A
|
G protein-coupled receptor, class C, group 5, member A
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX3
|
glutathione peroxidase 3
|
|
GRB10
|
growth factor receptor-bound protein 10
|
|
GRB14
|
growth factor receptor-bound protein 14
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRIN2D
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
|
GRN
|
granulin
|
|
GRP
|
gastrin-releasing peptide
|
|
GRPR
|
gastrin-releasing peptide receptor
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GSTK1
|
glutathione S-transferase kappa 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTF2I
|
general transcription factor IIi
|
|
GTF2IRD1
|
GTF2I repeat domain containing 1
|
|
GYPB
|
glycophorin B (MNS blood group)
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H2AFX
|
H2A histone family, member X
|
|
H2AFZ
|
H2A histone family, member Z
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAS2
|
hyaluronan synthase 2
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBB
|
hemoglobin, beta
|
|
HCAR1
|
hydroxycarboxylic acid receptor 1
|
|
HCAR2
|
hydroxycarboxylic acid receptor 2
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC6
|
histone deacetylase 6
|
|
HDC
|
histidine decarboxylase
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HERPUD1
|
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HES5
|
hes family bHLH transcription factor 5
|
|
HFE
|
hemochromatosis
|
|
HFE2
|
hemochromatosis type 2 (juvenile)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHIP
|
hedgehog interacting protein
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HINT1
|
histidine triad nucleotide binding protein 1
|
|
HIP1R
|
huntingtin interacting protein 1 related
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HIST2H2AC
|
histone cluster 2, H2ac
|
|
HIST2H2BE
|
histone cluster 2, H2be
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMHA1
|
histocompatibility (minor) HA-1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOPX
|
HOP homeobox
|
|
HOXA10
|
homeobox A10
|
|
HOXA9
|
homeobox A9
|
|
HP
|
haptoglobin
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH1
|
histamine receptor H1
|
|
HRH2
|
histamine receptor H2
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSF2
|
heat shock transcription factor 2
|
|
HSF4
|
heat shock transcription factor 4
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HSPE1
|
heat shock 10kDa protein 1
|
|
HTATSF1
|
HIV-1 Tat specific factor 1
|
|
HTL
|
high L-leucine transport
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTT
|
huntingtin
|
|
IAPP
|
islet amyloid polypeptide
|
|
IBSP
|
integrin-binding sialoprotein
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM2
|
intercellular adhesion molecule 2
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IER3
|
immediate early response 3
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL2
|
interferon, lambda 2
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
IGHV4-59
|
immunoglobulin heavy variable 4-59
|
|
IGK
|
immunoglobulin kappa locus
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL17RD
|
interleukin 17 receptor D
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL27
|
interleukin 27
|
|
IL31RA
|
interleukin 31 receptor A
|
|
IL32
|
interleukin 32
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7
|
interleukin 7
|
|
IL9
|
interleukin 9
|
|
ILK
|
integrin-linked kinase
|
|
INA
|
internexin neuronal intermediate filament protein, alpha
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INHBA
|
inhibin, beta A
|
|
INPP5J
|
inositol polyphosphate-5-phosphatase J
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRF8
|
interferon regulatory factor 8
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
IRX1
|
iroquois homeobox 1
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITM2B
|
integral membrane protein 2B
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JDP2
|
Jun dimerization protein 2
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KATNB1
|
katanin p80 (WD repeat containing) subunit B 1
|
|
KAZN
|
kazrin, periplakin interacting protein
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ13
|
potassium channel, inwardly rectifying subfamily J, member 13
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIAA1456
|
KIAA1456
|
|
KIF11
|
kinesin family member 11
|
|
KIF17
|
kinesin family member 17
|
|
KIF18A
|
kinesin family member 18A
|
|
KIF1B
|
kinesin family member 1B
|
|
KIF5A
|
kinesin family member 5A
|
|
KIF5B
|
kinesin family member 5B
|
|
KIFC1
|
kinesin family member C1
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLF11
|
Kruppel-like factor 11
|
|
KLF14
|
Kruppel-like factor 14
|
|
KLF16
|
Kruppel-like factor 16
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF8
|
Kruppel-like factor 8
|
|
KLF9
|
Kruppel-like factor 9
|
|
KLHL20
|
kelch-like family member 20
|
|
KLK1
|
kallikrein 1
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KNG1
|
kininogen 1
|
|
KPNB1
|
karyopherin (importin) beta 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT17
|
keratin 17, type I
|
|
KRT18
|
keratin 18, type I
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMA2
|
laminin, alpha 2
|
|
LAMA3
|
laminin, alpha 3
|
|
LAMB2
|
laminin, beta 2 (laminin S)
|
|
LAMB3
|
laminin, beta 3
|
|
LAMC2
|
laminin, gamma 2
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LARS2
|
leucyl-tRNA synthetase 2, mitochondrial
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LAX1
|
lymphocyte transmembrane adaptor 1
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LCOR
|
ligand dependent nuclear receptor corepressor
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LCT
|
lactase
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LHX4
|
LIM homeobox 4
|
|
LIF
|
leukemia inhibitory factor
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIN9
|
lin-9 DREAM MuvB core complex component
|
|
LIPF
|
lipase, gastric
|
|
LIPG
|
lipase, endothelial
|
|
LITAF
|
lipopolysaccharide-induced TNF factor
|
|
LMNA
|
lamin A/C
|
|
LMO4
|
LIM domain only 4
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPL
|
lipoprotein lipase
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP1B
|
low density lipoprotein receptor-related protein 1B
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRC3B
|
leucine rich repeat containing 3B
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
LTF
|
lactotransferrin
|
|
LY6E
|
lymphocyte antigen 6 complex, locus E
|
|
LY6K
|
lymphocyte antigen 6 complex, locus K
|
|
LY96
|
lymphocyte antigen 96
|
|
LYL1
|
lymphoblastic leukemia associated hematopoiesis regulator 1
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LYPD3
|
LY6/PLAUR domain containing 3
|
|
LYRM4
|
LYR motif containing 4
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1BP
|
MAD2L1 binding protein
|
|
MAD2L2
|
MAD2 mitotic arrest deficient-like 2 (yeast)
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAGEA1
|
melanoma antigen family A1
|
|
MAGEA11
|
melanoma antigen family A11
|
|
MAOA
|
monoamine oxidase A
|
|
MAP1A
|
microtubule-associated protein 1A
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K5
|
mitogen-activated protein kinase kinase 5
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP4
|
microtubule-associated protein 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MASTL
|
microtubule associated serine/threonine kinase-like
|
|
MAX
|
MYC associated factor X
|
|
MB
|
myoglobin
|
|
MBD3
|
methyl-CpG binding domain protein 3
|
|
MBL1P
|
mannose-binding lectin (protein A) 1, pseudogene
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCHR1
|
melanin-concentrating hormone receptor 1
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED25
|
mediator complex subunit 25
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEFV
|
Mediterranean fever
|
|
MELK
|
maternal embryonic leucine zipper kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase)
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MID1
|
midline 1
|
|
MIP
|
major intrinsic protein of lens fiber
|
|
MIR1225
|
microRNA 1225
|
|
MIR1228
|
microRNA 1228
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR125B2
|
microRNA 125b-2
|
|
MIR128-1
|
microRNA 128-1
|
|
MIR128-2
|
microRNA 128-2
|
|
MIR1285-1
|
microRNA 1285-1
|
|
MIR133A1
|
microRNA 133a-1
|
|
MIR137
|
microRNA 137
|
|
MIR140
|
microRNA 140
|
|
MIR142
|
microRNA 142
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR148A
|
microRNA 148a
|
|
MIR150
|
microRNA 150
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR15B
|
microRNA 15b
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR190A
|
microRNA 190a
|
|
MIR1915
|
microRNA 1915
|
|
MIR192
|
microRNA 192
|
|
MIR196A1
|
microRNA 196a-1
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR200A
|
microRNA 200a
|
|
MIR200B
|
microRNA 200b
|
|
MIR204
|
microRNA 204
|
|
MIR212
|
microRNA 212
|
|
MIR218-1
|
microRNA 218-1
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR29C
|
microRNA 29c
|
|
MIR30B
|
microRNA 30b
|
|
MIR31
|
microRNA 31
|
|
MIR34A
|
microRNA 34a
|
|
MIR372
|
microRNA 372
|
|
MIR375
|
microRNA 375
|
|
MIR376A1
|
microRNA 376a-1
|
|
MIR451A
|
microRNA 451a
|
|
MIR485
|
microRNA 485
|
|
MIR487B
|
microRNA 487b
|
|
MIR489
|
microRNA 489
|
|
MIR637
|
microRNA 637
|
|
MIR655
|
microRNA 655
|
|
MIR93
|
microRNA 93
|
|
MIR99A
|
microRNA 99a
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MIRLET7A3
|
microRNA let-7a-3
|
|
MIRLET7B
|
microRNA let-7b
|
|
MIS12
|
MIS12 kinetochore complex component
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1
|
|
MLH1
|
mutL homolog 1
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MLNR
|
motilin receptor
|
|
MLXIPL
|
MLX interacting protein-like
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP28
|
matrix metallopeptidase 28
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MPZ
|
myelin protein zero
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MRPL41
|
mitochondrial ribosomal protein L41
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSRB3
|
methionine sulfoxide reductase B3
|
|
MST1
|
macrophage stimulating 1
|
|
MT-ATP6
|
ATP synthase F0 subunit 6
|
|
MTA1
|
metastasis associated 1
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTERF1
|
mitochondrial transcription termination factor 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
|
MUTYH
|
mutY homolog
|
|
MVP
|
major vault protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYLIP
|
myosin regulatory light chain interacting protein
|
|
MYLK
|
myosin light chain kinase
|
|
MYO6
|
myosin VI
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYOD1
|
myogenic differentiation 1
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAPA
|
N-ethylmaleimide-sensitive factor attachment protein, alpha
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF1C
|
neutrophil cytosolic factor 1C pseudogene
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NCK1
|
NCK adaptor protein 1
|
|
NCK2
|
NCK adaptor protein 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NDC80
|
NDC80 kinetochore complex component
|
|
NDNF
|
neuron-derived neurotrophic factor
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NEFH
|
neurofilament, heavy polypeptide
|
|
NEK2
|
NIMA-related kinase 2
|
|
NEK3
|
NIMA-related kinase 3
|
|
NES
|
nestin
|
|
NET1
|
neuroepithelial cell transforming 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFASC
|
neurofascin
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFE2L1
|
nuclear factor, erythroid 2-like 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFE4
|
nuclear factor, erythroid 4
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NGLY1
|
N-glycanase 1
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NLGN1
|
neuroligin 1
|
|
NLRC4
|
NLR family, CARD domain containing 4
|
|
NLRC5
|
NLR family, CARD domain containing 5
|
|
NLRP1
|
NLR family, pyrin domain containing 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NLRP4
|
NLR family, pyrin domain containing 4
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NME8
|
NME/NM23 family member 8
|
|
NMNAT2
|
nicotinamide nucleotide adenylyltransferase 2
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOX4
|
NADPH oxidase 4
|
|
NPAS4
|
neuronal PAS domain protein 4
|
|
NPC1L1
|
NPC1-like 1
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPLOC4
|
nuclear protein localization 4 homolog (S. cerevisiae)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPC
|
natriuretic peptide C
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NPY1R
|
neuropeptide Y receptor Y1
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1
|
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRCAM
|
neuronal cell adhesion molecule
|
|
NRG1
|
neuregulin 1
|
|
NRGN
|
neurogranin (protein kinase C substrate, RC3)
|
|
NRP1
|
neuropilin 1
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTF3
|
neurotrophin 3
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NTS
|
neurotensin
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUDT5
|
nudix (nucleoside diphosphate linked moiety X)-type motif 5
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
NUMB
|
numb homolog (Drosophila)
|
|
NUP98
|
nucleoporin 98kDa
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OLA1
|
Obg-like ATPase 1
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPCML
|
opioid binding protein/cell adhesion molecule-like
|
|
OPN4
|
opsin 4
|
|
OPN5
|
opsin 5
|
|
OPRL1
|
opiate receptor-like 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORAOV1
|
oral cancer overexpressed 1
|
|
OTC
|
ornithine carbamoyltransferase
|
|
OTX2
|
orthodenticle homeobox 2
|
|
OXTR
|
oxytocin receptor
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
P4HTM
|
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PACS1
|
phosphofurin acidic cluster sorting protein 1
|
|
PADI2
|
peptidyl arginine deiminase, type II
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAFAH1B1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
|
|
PAFAH1B2
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa)
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PANX1
|
pannexin 1
|
|
PAPOLA
|
poly(A) polymerase alpha
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARG
|
poly (ADP-ribose) glycohydrolase
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX2
|
paired box 2
|
|
PAX6
|
paired box 6
|
|
PAX8
|
paired box 8
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PCDH15
|
protocadherin-related 15
|
|
PCDH17
|
protocadherin 17
|
|
PCMT1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
|
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent
|
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
|
PDK3
|
pyruvate dehydrogenase kinase, isozyme 3
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDYN
|
prodynorphin
|
|
PDZK1
|
PDZ domain containing 1
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER1
|
period circadian clock 1
|
|
PES1
|
pescadillo ribosomal biogenesis factor 1
|
|
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
|
|
PGF
|
placental growth factor
|
|
PGLYRP1
|
peptidoglycan recognition protein 1
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PHGDH
|
phosphoglycerate dehydrogenase
|
|
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
|
PIAS4
|
protein inhibitor of activated STAT, 4
|
|
PIDD1
|
p53-induced death domain protein 1
|
|
PIGR
|
polymeric immunoglobulin receptor
|
|
PIK3C2B
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PITX1
|
paired-like homeodomain 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PITX3
|
paired-like homeodomain 3
|
|
PKP1
|
plakophilin 1
|
|
PKP2
|
plakophilin 2
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLET1
|
placenta expressed transcript 1
|
|
PLG
|
plasminogen
|
|
PLK1
|
polo-like kinase 1
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PLXNB3
|
plexin B3
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
PMP22
|
peripheral myelin protein 22
|
|
PNOC
|
prepronociceptin
|
|
PNP
|
purine nucleoside phosphorylase
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
PNPLA6
|
patatin-like phospholipase domain containing 6
|
|
PODXL
|
podocalyxin-like
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLI
|
polymerase (DNA directed) iota
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU2F3
|
POU class 2 homeobox 3
|
|
POU4F1
|
POU class 4 homeobox 1
|
|
POU4F2
|
POU class 4 homeobox 2
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP1R15A
|
protein phosphatase 1, regulatory subunit 15A
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP1R1C
|
protein phosphatase 1, regulatory (inhibitor) subunit 1C
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha
|
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
|
PPP3CC
|
protein phosphatase 3, catalytic subunit, gamma isozyme
|
|
PPP5C
|
protein phosphatase 5, catalytic subunit
|
|
PRC1
|
protein regulator of cytokinesis 1
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRDX5
|
peroxiredoxin 5
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRG4
|
proteoglycan 4
|
|
PRIM1
|
primase, DNA, polypeptide 1 (49kDa)
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCDBP
|
protein kinase C, delta binding protein
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKD1
|
protein kinase D1
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PRMT6
|
protein arginine methyltransferase 6
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROK2
|
prokineticin 2
|
|
PROM1
|
prominin 1
|
|
PROP1
|
PROP paired-like homeobox 1
|
|
PROX1
|
prospero homeobox 1
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PRPH
|
peripherin
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PRSS2
|
protease, serine, 2 (trypsin 2)
|
|
PRSS36
|
protease, serine, 36
|
|
PRSS8
|
protease, serine, 8
|
|
PRTN3
|
proteinase 3
|
|
PSD
|
pleckstrin and Sec7 domain containing
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PSMD4
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
|
|
PSME3
|
proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)
|
|
PSMF1
|
proteasome (prosome, macropain) inhibitor subunit 1 (PI31)
|
|
PTAFR
|
platelet-activating factor receptor
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTRF
|
polymerase I and transcript release factor
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTX3
|
pentraxin 3, long
|
|
PURA
|
purine-rich element binding protein A
|
|
PVR
|
poliovirus receptor
|
|
PVT1
|
Pvt1 oncogene (non-protein coding)
|
|
PXN
|
paxillin
|
|
PYGM
|
phosphorylase, glycogen, muscle
|
|
PYY
|
peptide YY
|
|
QRFP
|
pyroglutamylated RFamide peptide
|
|
QSOX1
|
quiescin Q6 sulfhydryl oxidase 1
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAB4A
|
RAB4A, member RAS oncogene family
|
|
RAB5A
|
RAB5A, member RAS oncogene family
|
|
RAB6C
|
RAB6C, member RAS oncogene family
|
|
RAB7A
|
RAB7A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD18
|
RAD18 E3 ubiquitin protein ligase
|
|
RAD23A
|
RAD23 homolog A (S. cerevisiae)
|
|
RAD23B
|
RAD23 homolog B (S. cerevisiae)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG2
|
recombination activating gene 2
|
|
RALBP1
|
ralA binding protein 1
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
|
RAMP3
|
receptor (G protein-coupled) activity modifying protein 3
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RANBP2
|
RAN binding protein 2
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASAL1
|
RAS protein activator like 1 (GAP1 like)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RBL1
|
retinoblastoma-like 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBM24
|
RNA binding motif protein 24
|
|
RBM5
|
RNA binding motif protein 5
|
|
RBMXP1
|
RNA binding motif protein, X-linked pseudogene 1
|
|
RBP3
|
retinol binding protein 3, interstitial
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
RECQL
|
RecQ helicase-like
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELN
|
reelin
|
|
REM2
|
RAS (RAD and GEM)-like GTP binding 2
|
|
REN
|
renin
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RGMA
|
repulsive guidance molecule family member a
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHCG
|
Rh family, C glycoprotein
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOC
|
ras homolog family member C
|
|
RHOU
|
ras homolog family member U
|
|
RHOV
|
ras homolog family member V
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNF41
|
ring finger protein 41, E3 ubiquitin protein ligase
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RPAP3
|
RNA polymerase II associated protein 3
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPL37
|
ribosomal protein L37
|
|
RPS15
|
ribosomal protein S15
|
|
RPS19
|
ribosomal protein S19
|
|
RPS20
|
ribosomal protein S20
|
|
RPS3
|
ribosomal protein S3
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KA6
|
ribosomal protein S6 kinase, 90kDa, polypeptide 6
|
|
RREB1
|
ras responsive element binding protein 1
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
|
RSAD2
|
radical S-adenosyl methionine domain containing 2
|
|
RTN3
|
reticulon 3
|
|
RTN4
|
reticulon 4
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
RYR3
|
ryanodine receptor 3
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
SAA1
|
serum amyloid A1
|
|
SALL3
|
spalt-like transcription factor 3
|
|
SAPCD2
|
suppressor APC domain containing 2
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SCAF1
|
SR-related CTD-associated factor 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCG2
|
secretogranin II
|
|
SCGN
|
secretagogin, EF-hand calcium binding protein
|
|
SCLY
|
selenocysteine lyase
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SDC2
|
syndecan 2
|
|
SELENBP1
|
selenium binding protein 1
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMG1
|
semenogelin I
|
|
SENP1
|
SUMO1/sentrin specific peptidase 1
|
|
SEPN1
|
selenoprotein N, 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SETDB1
|
SET domain, bifurcated 1
|
|
SF1
|
splicing factor 1
|
|
SFMBT1
|
Scm-like with four mbt domains 1
|
|
SFN
|
stratifin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPA2
|
surfactant protein A2
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SH3GLB1
|
SH3-domain GRB2-like endophilin B1
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SHOX
|
short stature homeobox
|
|
SIAH1
|
siah E3 ubiquitin protein ligase 1
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT1
|
sirtuin 1
|
|
SIRT3
|
sirtuin 3
|
|
SIRT5
|
sirtuin 5
|
|
SIRT6
|
sirtuin 6
|
|
SIX1
|
SIX homeobox 1
|
|
SIX6
|
SIX homeobox 6
|
|
SKAP1
|
src kinase associated phosphoprotein 1
|
|
SKI
|
SKI proto-oncogene
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLBP
|
stem-loop binding protein
|
|
SLC10A2
|
solute carrier family 10 (sodium/bile acid cotransporter), member 2
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2
|
|
SLC19A3
|
solute carrier family 19 (thiamine transporter), member 3
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC20A1
|
solute carrier family 20 (phosphate transporter), member 1
|
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2
|
|
SLC22A2
|
solute carrier family 22 (organic cation transporter), member 2
|
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3
|
|
SLC23A1
|
solute carrier family 23 (ascorbic acid transporter), member 1
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC25A37
|
solute carrier family 25 (mitochondrial iron transporter), member 37
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC31A1
|
solute carrier family 31 (copper transporter), member 1
|
|
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 1
|
|
SLC34A3
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 3
|
|
SLC38A1
|
solute carrier family 38, member 1
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC44A1
|
solute carrier family 44 (choline transporter), member 1
|
|
SLC46A1
|
solute carrier family 46 (folate transporter), member 1
|
|
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4
|
|
SLC52A1
|
solute carrier family 52 (riboflavin transporter), member 1
|
|
SLC52A3
|
solute carrier family 52 (riboflavin transporter), member 3
|
|
SLC5A2
|
solute carrier family 5 (sodium/glucose cotransporter), member 2
|
|
SLC5A3
|
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC5A8
|
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD6
|
SMAD family member 6
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMUG1
|
single-strand-selective monofunctional uracil-DNA glycosylase 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCAIP
|
synuclein, alpha interacting protein
|
|
SNCB
|
synuclein, beta
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS5
|
suppressor of cytokine signaling 5
|
|
SOCS6
|
suppressor of cytokine signaling 6
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SON
|
SON DNA binding protein
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SORT1
|
sortilin 1
|
|
SOX17
|
SRY (sex determining region Y)-box 17
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPAST
|
spastin
|
|
SPATS2L
|
spermatogenesis associated, serine-rich 2-like
|
|
SPECC1L
|
sperm antigen with calponin homology and coiled-coil domains 1-like
|
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPR
|
sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
|
SPRED2
|
sprouty-related, EVH1 domain containing 2
|
|
SPRR1B
|
small proline-rich protein 1B
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPTA1
|
spectrin, alpha, erythrocytic 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRCAP
|
Snf2-related CREBBP activator protein
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SRY
|
sex determining region Y
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SSRP1
|
structure specific recognition protein 1
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1
|
|
STAG2
|
stromal antigen 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STX1A
|
syntaxin 1A (brain)
|
|
STX6
|
syntaxin 6
|
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUN1
|
Sad1 and UNC84 domain containing 1
|
|
SYK
|
spleen tyrosine kinase
|
|
SYTL4
|
synaptotagmin-like 4
|
|
TAAR1
|
trace amine associated receptor 1
|
|
TAAR6
|
trace amine associated receptor 6
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
|
TAC1
|
tachykinin, precursor 1
|
|
TAC3
|
tachykinin 3
|
|
TACC3
|
transforming, acidic coiled-coil containing protein 3
|
|
TACR1
|
tachykinin receptor 1
|
|
TACR3
|
tachykinin receptor 3
|
|
TAF5L
|
TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TBCB
|
tubulin folding cofactor B
|
|
TBCE
|
tubulin folding cofactor E
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBP
|
TATA box binding protein
|
|
TBX20
|
T-box 20
|
|
TBX21
|
T-box 21
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCF3
|
transcription factor 3
|
|
TCF4
|
transcription factor 4
|
|
TCF7L1
|
transcription factor 7-like 1 (T-cell specific, HMG-box)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TDO2
|
tryptophan 2,3-dioxygenase
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TF
|
transferrin
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFRC
|
transferrin receptor
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THOC1
|
THO complex 1
|
|
THPO
|
thrombopoietin
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TJP1
|
tight junction protein 1
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TMBIM6
|
transmembrane BAX inhibitor motif containing 6
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF8
|
tumor necrosis factor (ligand) superfamily, member 8
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TRA
|
T cell receptor alpha locus
|
|
TRA2B
|
transformer 2 beta homolog (Drosophila)
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRB
|
T cell receptor beta locus
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM22
|
tripartite motif containing 22
|
|
TRIM31
|
tripartite motif containing 31
|
|
TRIM37
|
tripartite motif containing 37
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM5
|
transient receptor potential cation channel, subfamily M, member 5
|
|
TRPM6
|
transient receptor potential cation channel, subfamily M, member 6
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPO
|
translocator protein (18kDa)
|
|
TSTD1
|
thiosulfate sulfurtransferase (rhodanese)-like domain containing 1
|
|
TTBK1
|
tau tubulin kinase 1
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TTR
|
transthyretin
|
|
TUBA1A
|
tubulin, alpha 1a
|
|
TUSC1
|
tumor suppressor candidate 1
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXN
|
thioredoxin
|
|
TXNL1
|
thioredoxin-like 1
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
TYMP
|
thymidine phosphorylase
|
|
U2AF2
|
U2 small nuclear RNA auxiliary factor 2
|
|
UBC
|
ubiquitin C
|
|
UBE2D1
|
ubiquitin-conjugating enzyme E2D 1
|
|
UBE2W
|
ubiquitin-conjugating enzyme E2W (putative)
|
|
UBE4B
|
ubiquitination factor E4B
|
|
UBQLN4
|
ubiquilin 4
|
|
UCN2
|
urocortin 2
|
|
UCN3
|
urocortin 3
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UFD1L
|
ubiquitin fusion degradation 1 like (yeast)
|
|
UGT1A
|
UDP glucuronosyltransferase 1 family, polypeptide A complex locus
|
|
UGT1A3
|
UDP glucuronosyltransferase 1 family, polypeptide A3
|
|
UIMC1
|
ubiquitin interaction motif containing 1
|
|
UMPS
|
uridine monophosphate synthetase
|
|
UNC93B1
|
unc-93 homolog B1 (C. elegans)
|
|
UNG
|
uracil-DNA glycosylase
|
|
UQCC1
|
ubiquinol-cytochrome c reductase complex assembly factor 1
|
|
UQCRH
|
ubiquinol-cytochrome c reductase hinge protein
|
|
USP1
|
ubiquitin specific peptidase 1
|
|
USP18
|
ubiquitin specific peptidase 18
|
|
USP9X
|
ubiquitin specific peptidase 9, X-linked
|
|
UVRAG
|
UV radiation resistance associated
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VAV2
|
vav 2 guanine nucleotide exchange factor
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VCP
|
valosin containing protein
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VWF
|
von Willebrand factor
|
|
WARS
|
tryptophanyl-tRNA synthetase
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WFDC21P
|
WAP four-disulfide core domain 21, pseudogene
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WSB1
|
WD repeat and SOCS box containing 1
|
|
WT1
|
Wilms tumor 1
|
|
WWP1
|
WW domain containing E3 ubiquitin protein ligase 1
|
|
XBP1
|
X-box binding protein 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XPNPEP2
|
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YBX3
|
Y box binding protein 3
|
|
YRDC
|
yrdC N(6)-threonylcarbamoyltransferase domain containing
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
YY1
|
YY1 transcription factor
|
|
YY2
|
YY2 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBP1
|
Z-DNA binding protein 1
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZBTB7B
|
zinc finger and BTB domain containing 7B
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFHX3
|
zinc finger homeobox 3
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZFPM1
|
zinc finger protein, FOG family member 1
|
|
ZHX2
|
zinc fingers and homeoboxes 2
|
|
ZMYND10
|
zinc finger, MYND-type containing 10
|
|
ZNF143
|
zinc finger protein 143
|
|
ZNF37A
|
zinc finger protein 37A
|
|
ZNF385A
|
zinc finger protein 385A
|
|
ZNF804A
|
zinc finger protein 804A
|
